Get started
Author

Mattia Lauriola

Observed names: Lauriola, Mattia, M Lauriola, M. Lauriola
ORCID: 0000-0002-7966-0065
Observed ORCID: 0000-0002-7966-0065
OpenAlex ID: A5135618311
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies
2026 · Valerio Gelfo, Federica Pagano, et al. · Seminars in Immunology · 1
Structure-guided identification of small molecules potentially able to modulate GDF15 activity
2026 · Antonio Chiariello, Lorenzo Lenti, et al. · Scientific Reports · 1
PDF
Hierarchical and context-dependent GR-MR signalling governs endogenous corticosteroid decoding in the heart
2026 · F. Sacchi, S. Boriati, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Characterization of primary three-dimensional cell culture from spontaneous canine tumors
2026 · Francesco Borrelli, Chiara Tugnoli, et al. · Research in Veterinary Science
Nuclear Mechanotransduction at the Crossroads: How Membrane Receptors Remodel the Perinuclear Cytoskeleton to Drive Cancer and Disease
2026 · Michela Sgarzi, Elisa Montacci, et al. · International Journal of Biological Sciences
Neuroendocrine-like/EMT dedifferentiation mediates resistance to EGFR inhibitors via the NRG1/HER3 axis
2026 · Alessandra Morselli, Chiara Miroglio, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Standardization and Characterization of Primary Three-Dimensional Cell Culture Protocols for Spontaneous Canine Tumors
2026 · Francesco Borrelli, Chiara Tugnoli, et al. · SSRN Electronic Journal
Tessuto Osseo Gruppo 2
2018 · Lauriola, Mattia · AMS Campus - AlmaDL
Tessuto Osseo Gruppo 3
2018 · Lauriola, Mattia · AMS Campus - AlmaDL
Works count: 10
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type